EW

Edwards Lifesciences Stock Analysis

AI Rating

Neutral
  • Quality9/10
  • Growth 3/10
  • Momentum 4/10
Edwards Lifesciences sales and earnings growth
EW Growth
Neutral
  • Revenue Y/Y 10.60%
  • EPS Y/Y -66.14%
  • FCF Y/Y 56.00%
Edwards Lifesciences gross and profit margin trends
EW Profitability
Great
  • Gross margin 78.20%
  • EPS margin 23.20%
  • ROIC 25.10%
Edwards Lifesciences net debt vs free cash flow
EW Risk
Great
  • Debt / Equity 0.1
  • Debt / FCF 0.0
  • Interest coverage 82.0

Edwards Lifesciences stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Medical Devices stocks ↗